• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤患者中CD4 + T细胞对SSX - 4的反应。

CD4+ T cell responses to SSX-4 in melanoma patients.

作者信息

Ayyoub Maha, Merlo Andrea, Hesdorffer Charles S, Rimoldi Donata, Speiser Daniel, Cerottini Jean-Charles, Chen Yao-Tseng, Old Lloyd J, Stevanovic Stefan, Valmori Danila

机构信息

Ludwig Institute Clinical Trial Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.

出版信息

J Immunol. 2005 Apr 15;174(8):5092-9. doi: 10.4049/jimmunol.174.8.5092.

DOI:10.4049/jimmunol.174.8.5092
PMID:15814740
Abstract

Genes of the synovial sarcoma X breakpoint (SSX) family are expressed in different human tumors, including melanomas, but not in adult somatic tissues. Because of their specific expression at the tumor site, SSX-encoded Ags are potential targets for anticancer immunotherapy. In this study, we have analyzed CD4+ T cell responses directed against the Ag encoded by SSX-4. Upon in vitro stimulation of PBMC from four melanoma patients bearing Ag-expressing tumors with a pool of long peptides spanning the protein sequence, we detected and isolated SSX-4-specific CD4+ T cells recognizing several distinct antigenic sequences, mostly restricted by frequently expressed HLA class II alleles. The majority of the identified sequences were located within the Krüppel-associated box domain in the N-terminal region of the protein, indicating a high potential immunogenicity of this region. Together our data document the existence of CD4+ T cells specific for multiple SSX-4 derived sequences in circulating lymphocytes from melanoma patients and encourage further studies to assess the impact of SSX-4-specific T cell responses on disease evolution in cancer patients.

摘要

滑膜肉瘤X断点(SSX)家族的基因在包括黑色素瘤在内的不同人类肿瘤中表达,但在成人体细胞组织中不表达。由于它们在肿瘤部位的特异性表达,SSX编码的抗原是抗癌免疫治疗的潜在靶点。在本研究中,我们分析了针对SSX - 4编码抗原的CD4 + T细胞反应。在用跨越蛋白质序列的一组长肽体外刺激来自四名携带表达抗原肿瘤的黑色素瘤患者的外周血单核细胞(PBMC)后,我们检测并分离出了识别几种不同抗原序列的SSX - 4特异性CD4 + T细胞,这些序列大多受频繁表达的HLA II类等位基因限制。大多数已鉴定的序列位于蛋白质N端区域的Krüppel相关盒结构域内,表明该区域具有高度潜在免疫原性。我们的数据共同证明了黑色素瘤患者循环淋巴细胞中存在针对多个SSX - 4衍生序列的CD4 + T细胞,并鼓励进一步研究以评估SSX - 4特异性T细胞反应对癌症患者疾病进展的影响。

相似文献

1
CD4+ T cell responses to SSX-4 in melanoma patients.黑色素瘤患者中CD4 + T细胞对SSX - 4的反应。
J Immunol. 2005 Apr 15;174(8):5092-9. doi: 10.4049/jimmunol.174.8.5092.
2
Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.对无癌个体中肿瘤抗原SSX - 1特异性CD4 + T细胞的评估。
Cancer Immunol Immunother. 2007 Aug;56(8):1183-92. doi: 10.1007/s00262-006-0269-9. Epub 2006 Dec 22.
3
Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.滑膜肉瘤X(SSX)抗原在上皮性卵巢癌中的表达及CD4 + T细胞识别的SSX - 4表位的鉴定。
Clin Cancer Res. 2006 Jan 15;12(2):398-404. doi: 10.1158/1078-0432.CCR-05-1902.
4
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.
J Immunol. 2004 Jun 1;172(11):7206-11. doi: 10.4049/jimmunol.172.11.7206.
5
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.蛋白酶体辅助鉴定出一种由SSX-2衍生的表位,该表位可被浸润转移性黑色素瘤的肿瘤反应性细胞毒性T淋巴细胞识别。
J Immunol. 2002 Feb 15;168(4):1717-22. doi: 10.4049/jimmunol.168.4.1717.
6
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.SSX-2 蛋白 37-58 区域中不同但相互重叠的辅助性 T 细胞表位。
Clin Immunol. 2005 Jan;114(1):70-8. doi: 10.1016/j.clim.2004.08.014.
7
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.一种与HLA - DR相关的、可被CD4 + T细胞识别的免疫显性SSX - 2衍生表位。
J Clin Invest. 2004 Apr;113(8):1225-33. doi: 10.1172/JCI20667.
8
Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.SSX 家族癌症睾丸抗原在前列腺癌中的表达和免疫治疗靶向。
Cancer Res. 2011 Nov 1;71(21):6785-95. doi: 10.1158/0008-5472.CAN-11-2127. Epub 2011 Aug 31.
9
Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy.通过模拟改变的肽配体策略鉴定SSX家族成员中一个常见的HLA-A*0201限制性表位。
Mol Immunol. 2008 May;45(9):2455-64. doi: 10.1016/j.molimm.2008.01.014. Epub 2008 Mar 4.
10
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.源自酪氨酸酶相关蛋白-2和gp100黑色素瘤抗原的新型HLA-Cw8限制性T细胞表位。
J Immunol. 1999 Feb 1;162(3):1739-48.

引用本文的文献

1
Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.治疗性癌症疫苗——抗原发现与佐剂递送平台
Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448.
2
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.免疫和遗传机制在滑膜肉瘤中塑造致癌程序。
Nat Med. 2021 Feb;27(2):289-300. doi: 10.1038/s41591-020-01212-6. Epub 2021 Jan 25.
3
Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1.LAGE-1 自发性 CD4+ T 细胞反应的表位层次结构。
J Immunol. 2011 Jan 1;186(1):312-22. doi: 10.4049/jimmunol.1001989. Epub 2010 Dec 3.
4
The SSX family of cancer-testis antigens as target proteins for tumor therapy.作为肿瘤治疗靶蛋白的癌-睾丸抗原SSX家族。
Clin Dev Immunol. 2010;2010:150591. doi: 10.1155/2010/150591. Epub 2010 Oct 11.
5
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.一例对化疗和免疫疗法敏感的转移性黑色素瘤罕见病例,脑部出现晚期免疫逃逸。
Cancer Immun. 2008 Mar 27;8:6.
6
Changes in gene-expression profiles of colon carcinoma cells induced by wild type K-ras2.野生型K-ras2诱导的结肠癌细胞基因表达谱变化。
World J Gastroenterol. 2007 Sep 14;13(34):4620-5. doi: 10.3748/wjg.v13.i34.4620.
7
Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.对无癌个体中肿瘤抗原SSX - 1特异性CD4 + T细胞的评估。
Cancer Immunol Immunother. 2007 Aug;56(8):1183-92. doi: 10.1007/s00262-006-0269-9. Epub 2006 Dec 22.